Active
Mainboard

Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Ltd IPO opened on 20 Feb 2026 and closed on 24 Feb 2026, with a price band of ₹75–₹79 per share. The IPO had a lot size of 189 shares, requiring a minimum investment of ₹14,931 per lot at the upper price band. The issue size was ₹165 crore, and the shares get listed on 27 Feb 2026.

Gaudium IVF and Women Health Ltd IPO Details

Listing Date

27 Feb 2026

Bid Price

₹75 - ₹79

Lot Size

189 Shares

Minimum Investment

₹14,931 / Lot

Issue Size

₹165 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

20th Feb

tick

Offer End Date

24th Feb

tick

Allotment Date

25th Feb

tick

Refund Initiation

25th Feb

tick

Demat Transfer

26th Feb

tick

Listing Date

27th Feb

About Gaudium IVF and Women Health Ltd IPO

Incorporated in March 2015, Gaudium IVF and Women Health Limited is engaged in providing In Vitro Fertilization (IVF) treatments across India and has expanded into several states through a structured hub-and-spoke model. The company operates over thirty locations comprising seven hubs (centres) and twenty-eight spokes. It has entered into a strategic alliance with Infertility Experts, referred to as Spokes, with the objective of increasing awareness and accessibility of Assisted Reproductive Technology (ART) and IVF treatments. The company serves patients not only from India but also from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
 

The company has established centres in major cities including two in Delhi (Janakpuri and Kailash Colony) and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore. Its specialised fertility services include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), ovulation induction, and advanced male infertility treatments such as sperm retrieval techniques. In addition to fertility care, the company provides comprehensive gynaecological services for conditions such as PCOD/PCOS and endometriosis, along with high-risk pregnancy management for women with complex fertility histories or associated health conditions.

Gaudium IVF and Women Health Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 99.98% 71.3%
Public Group 0.02% 28.7%

Gaudium IVF and Women Health Ltd IPO Reservation

QIB Shares Offered 41,77,240 (20%)
NII (HNI) Shares Offered 31,32,930 (15%)
Retail Shares Offered 73,10,170 (35%)
Anchor Investor Shares Offered 62,65,860 (30%)
Total Shares Offered 2,08,86,200
Total Shares With Anchor Investor 2,08,86,200

Gaudium IVF and Women Health Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 189 ₹14,931
Retail (Max) 13 2,457 ₹1,94,103
S HNI (Min) 14 2,646 ₹2,09,034
S HNI (Max) 66 12,474 ₹9,85,446
B HNI (MIN) 67 12,663 ₹10,00,377

Gaudium IVF and Women Health Ltd IPO Anchor Portion Size

Bid Date February 19, 2026

Gaudium IVF and Women Health Ltd IPO registrar

Bigshare Services Pvt Ltd
Phone Number +91 22 6263 8200;
Email Id ipo@bigshareonline.com
Website www.bigshareonline.com

Gaudium IVF and Women Health Ltd IPO Lead Manager

1. Sarthi Capital Advisors Pvt Ltd

Gaudium IVF and Women Health Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹46.3 Cr ₹33.27 Cr ₹22.73 Cr
Reserves and Surplus ₹15.6 Cr ₹32.28 Cr ₹21.74 Cr
Total Borrowing ₹18.93 Cr ₹15.73 Cr ₹9.78 Cr

Gaudium IVF and Women Health Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 41,77,240 67,85,478 1.6244
Non Institutional Investors (NIIs) 31,32,930 4,39,60,266 14.0317
Retail Individual Investors (RIIs) 73,10,170 5,52,06,522 7.552
Total 1,46,20,340 10,59,52,266 7.25

Strength of Gaudium IVF and Women Health Ltd

  • Clinical excellence and advanced medical technologies to deliver quality healthcare.
  • Ability to attract, train and retain high-quality doctors and staff.
  • Scalable model and disciplined approach for growth.
  • Stable and robust financial performance.
  • Professional management and experienced leadership of our Promoters i.e., Manika Khanna and Peeyush Khanna.

Risks Involved

  • The Company is in engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), Egg Freezing, laser assisted embryo implantation amongst others and is subject to various operational, reputational, medical and legal risks associated with the operations of healthcare services. An inability to provide quality healthcare catering to the needs of the customers could adversely affect the reputation, business prospects and financial performance of the Company.
  • The Company may highly dependent on doctors, nurses and other healthcare professionals and the business will be impacted significantly if the Company is unable to attract / retain such professionals.
  • The business of the Company depends on the strength of the brand and reputation of the Company. Failure to maintain and enhance the brand and reputation, and any negative publicity and allegations in the media against the Company, even if untrue, may adversely affect the brand, reputation and trust in, services of the Company, which could result in a material adverse impact on business, financial condition, results of operations and prospects of the Company.
  • The Company may face challenges in further expanding operations in cities where the Company currently operate in or in other cities that the Company strategically intend to commence operations, which could have an adverse effect on the business prospects and future financial performance.
  • Our Company has experienced negative cash flows in the past. We cannot assure you that we will achieve or sustain profitability and not continue to incur losses going forward.
  • The failure to identify, understand and adapt to rapidly evolving technological advancements related to our medical equipment and technology could adversely affect our business prospects and financial performance.
  • If the Company fails to achieve favourable pricing from its suppliers or vendors, fail to negotiate favourable terms with its doctors, or fail to pass on any cost increases to the customers, its business, financial condition and profitability may be adversely impacted.
  • Failure or malfunction of our medical or other equipment, could adversely affect our ability to conduct our operations.
  • Proposed New IVF Centres of the Company may experience delays in construction, development and completion. Any delays in New IVF Center setup, due to unforeseen events, may lead to cost overruns and implementation delays, impacting our business growth.
  • For our business, we rely heavily on our Promoters namely, Dr. Manika Khanna and Dr. Peeyush Khanna. Our business performance may have an adverse effect by their departure or by our failure to recruit or keep them.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Gaudium IVF and Women Health IPO

  •  According to the Infomerics Research Report, the global IVF market was valued at approximately USD 27.49 billion in 2024 and is projected to reach about USD 54.60 billion by 2034, reflecting a compound annual growth rate (CAGR) of around 7.10%. This indicates sustained expansion in assisted reproductive services across developed and emerging markets.
  • India’s IVF market is expected to grow at a comparatively faster pace, increasing from an estimated USD 1.32 billion to USD 4.54 billion over the same period, at a CAGR of approximately 13.13%. The country’s share in the global IVF market is projected to expand from 4.8% to 8.3%, reflecting rising domestic demand and capacity expansion.
  • Growth in the sector is supported by factors such as increasing infertility rates, delayed marriages, changing lifestyle patterns, and rising maternal age, all of which contribute to higher demand for assisted reproductive technology (ART) services.
  • Technological advancements in fertility treatments, along with evolving regulatory frameworks and improved access to specialised healthcare facilities, are strengthening service adoption across urban and semi-urban centres.
  • A broader trend of declining global fertility rates has led to increasing reliance on IVF and related treatments, positioning India as a growing hub for reproductive healthcare services within the international landscape.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Gaudium IVF and Women Health IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Absolute Project India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Adroit Industries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
EMIAC TECHNOLOGIES LIMITED IPO
Bidding Period
27th Mar 2026 - 4th Apr 2026
Price Range
₹93.0 - 98.0
IPO Size
₹32,00,00,000
SAFETY CONTROLS AND DEVICES LIMITED IPO
Bidding Period
6th Apr 2026 - 4th Apr 2026
Price Range
₹75.0 - 80.0
IPO Size
₹48,00,00,000
VIVID ELECTROMECH LIMITED IPO
Bidding Period
25th Mar 2026 - 3rd Mar 2026
Price Range
₹528.0 - 555.0
IPO Size
₹1,31,00,00,000
SAI PARENTERAL'S LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹372.0 - 392.0
IPO Size
₹4,09,00,00,000
AMIR CHAND JAGDISH KUMAR EXPORTS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹201.0 - 212.0
IPO Size
₹4,40,00,00,000
HIGHNESS MICROELECTRONICS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹114.0 - 120.0
IPO Size
₹22,00,00,000
POWERICA LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹375.0 - 395.0
IPO Size
₹11,00,00,00,000
TIPCO ENGINEERING INDIA LIMITED IPO
Bidding Period
23rd Mar 2026 - 3rd Mar 2026
Price Range
₹84.0 - 89.0
IPO Size
₹61,00,00,000
SPECIALITY MEDICINES LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹117.0 - 124.0
IPO Size
₹29,00,00,000
CENTRAL MINE PLANNING AND DESIGN INSTITUTE LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹163.0 - 172.0
IPO Size
₹18,42,00,00,000
NOVUS LOYALTY LIMITED IPO
Bidding Period
17th Mar 2026 - 3rd Mar 2026
Price Range
₹139.0 - 146.0
IPO Size
₹60,00,00,000
GSP CROP SCIENCE LIMITED IPO
Bidding Period
16th Mar 2026 - 3rd Mar 2026
Price Range
₹304.0 - 320.0
IPO Size
₹4,00,00,00,000
INNOVISION LIMITED IPO
Bidding Period
10th Mar 2026 - 3rd Mar 2026
Price Range
₹494.0 - 519.0
IPO Size
₹3,06,00,00,000
RAAJMARG INFRA INVESTMENT TRUST IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹99.0 - 100.0
IPO Size
₹60,00,00,00,000
APSIS AEROCOM LIMITED IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹104.0 - 110.0
IPO Size
₹36,00,00,000
RAJPUTANA STAINLESS LIMITED IPO
Bidding Period
9th Mar 2026 - 3rd Mar 2026
Price Range
₹116.0 - 122.0
IPO Size
₹2,55,00,00,000
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Bidding Period
6th Mar 2026 - 3rd Mar 2026
Price Range
₹91.0 - 98.0
IPO Size
₹20,00,00,000
ELFIN AGRO INDIA LIMITED IPO
Bidding Period
5th Mar 2026 - 3rd Mar 2026
Price Range
₹47.0 - 47.0
IPO Size
₹25,00,00,000
SEDEMAC MECHATRONICS LIMITED IPO
Bidding Period
4th Mar 2026 - 3rd Mar 2026
Price Range
₹1287.0 - 1352.0
IPO Size
₹10,87,00,00,000
ACETECH ECOMMERCE LIMITED IPO
Bidding Period
27th Feb 2026 - 3rd Mar 2026
Price Range
₹106.0 - 112.0
IPO Size
₹49,00,00,000
  • All
  • MainBoard
  • SME
GSP CROP SCIENCE LIMITED IPO
Issue Prize
320.00
Listing Day Close
356.10(11.25%)
INNOVISION LIMITED IPO
Issue Prize
519.00
Listing Day Close
372.80(-28.13%)
RAAJMARG INFRA INVESTMENT TRUST IPO
Issue Prize
100.00
Listing Day Close
106.83(7.00%)
APSIS AEROCOM LIMITED IPO
Issue Prize
110.00
Listing Day Close
160.65(46.36%)
RAJPUTANA STAINLESS LIMITED IPO
Issue Prize
122.00
Listing Day Close
112.90(-7.38%)
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Issue Prize
98.00
Listing Day Close
104.40(6.12%)
ELFIN AGRO INDIA LIMITED IPO
Issue Prize
47.00
Listing Day Close
47.60(2.13%)
SEDEMAC MECHATRONICS LIMITED IPO
Issue Prize
1352.00
Listing Day Close
1452.10(7.40%)
ACETECH ECOMMERCE LIMITED IPO
Issue Prize
112.00
Listing Day Close
117.60(5.36%)
STRIDERS IMPEX LIMITED IPO
Issue Prize
72.00
Listing Day Close
66.50(-6.94%)
OMNITECH ENGINEERING LIMITED IPO
Issue Prize
227.00
Listing Day Close
205.15(-9.69%)
YAAP DIGITAL LIMITED IPO
Issue Prize
145.00
Listing Day Close
133.35(-8.28%)
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Issue Prize
386.00
Listing Day Close
413.95(7.25%)
SHREE RAM TWISTEX LIMITED IPO
Issue Prize
104.00
Listing Day Close
73.45(-29.81%)
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Issue Prize
1053.00
Listing Day Close
867.90(-17.57%)
MOBILISE APP LAB LIMITED IPO
Issue Prize
80.00
Listing Day Close
67.30(-16.25%)
KIAASA RETAIL LIMITED IPO
Issue Prize
127.00
Listing Day Close
116.85(-7.87%)
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Issue Prize
46.00
Listing Day Close
52.50(15.22%)
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Issue Prize
79.00
Listing Day Close
80.48(1.27%)
MANILAM INDUSTRIES INDIA LIMITED IPO
Issue Prize
69.00
Listing Day Close
52.45(-24.64%)

Frequently Asked Questions

What is Gaudium IVF and Women Health Ltd IPO?

Answer Field

Gaudium IVF and Women Health Ltd IPO is a Mainboard IPO of 2,08,86,200 equity shares of a face value of ₹5 aggregating up to ₹165 Crores. The issue is priced at ₹75 to ₹79 per share. The minimum order quantity is 189 Shares. The IPO opens on February 20, 2026, and closes on February 24, 2026. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Gaudium IVF and Women Health Ltd IPO will open?

Answer Field

The Gaudium IVF and Women Health Ltd IPO opens on February 20, 2026 and closes on February 24, 2026.

What is the lot size of Gaudium IVF and Women Health Ltd?

Answer Field

Gaudium IVF and Women Health Ltd lot size is 189 shares, and the minimum amount required is ₹14,931.

How to apply for Gaudium IVF and Women Health Ltd IPO?

Answer Field

You can apply in Gaudium IVF and Women Health Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Gaudium IVF and Women Health Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Gaudium IVF and Women Health Ltd IPO will be done on February 25, 2026, and the allotted shares will be credited to your demat account by February 26, 2026.

When is Gaudium IVF and Women Health Ltd IPO listing date?

Answer Field

The Gaudium IVF and Women Health Ltd listing date is February 27, 2026.

Who is the registrar of Gaudium IVF and Women Health Ltd IPO?

Answer Field

The registrar of Gaudium IVF and Women Health Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Sarthi Capital Advisors Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Gaudium IVF and Women Health Ltd IPO?

Answer Field

The fresh issue size is ₹90 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Gaudium IVF and Women Health Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 189 shares and ₹14,931 amount.

How can I approve the UPI mandate request for Gaudium IVF and Women Health Ltd IPO?

Answer Field

To apply for Gaudium IVF and Women Health Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Gaudium IVF and Women Health Ltd?

Answer Field

The price of each Gaudium IVF and Women Health Ltd share will be ranging in between ₹75 to ₹79 per share.

What is the cut-off time for the UPI mandate for Gaudium IVF and Women Health Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, February 24, 2026.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|